Affiliation:
1. Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Abstract
Interleukin-1 (IL-1) induced slow, lasting activation of human endothelial cells (EC) to release prostacyclin (PGI2). This was accompanied by endogenous 3H-arachidonic acid (3H-AA) release and by a time-dependent increase in the cells' ability to convert exogenous AA. The continuous presence of IL-1 was not required, but about a 1-hour stimulation with the cytokine was sufficient to trigger the cells to synthesize PGI2 for several hours. The spectrum of 3H-AA conversion shows that, in addition to 6-keto-prostaglandin F1 alpha, prostaglandin F2 alpha also was raised after IL-1. The recovery of PGI2 synthesis after aspirin was faster in IL-1-treated EC than in control cells. These data define some of the characteristics of IL-1 stimulation of PGI2 and suggest that this process is mediated both by endogenous AA mobilization and by an increase in cyclooxygenase activity.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference21 articles.
1. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin;Moncada S;Pharmacol Rev,1978
2. Prostacyclin production by human endothelial and bovine smooth muscle cells in culture
3. Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase.
4. Prostacyclin Synthesis Induced in Vascular Cells by Interleukin-1
5. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukln-1;Albrlghtson CR;J Immunol,1985
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献